Rivaroxaban reduces risk of venous thromboembolismTreatment with the oral factor Xa inhibitor rivaroxaban reduces the risk of recurrent venous thromboembolism—and it does so without an increase in bleeding, researchers said here. Resistant infections on rise among middle-age adultsU.S. hospital-based study documents two-decade drop in mean age since 1997 Abdominal massage eases constipation in MS patients Success of small feasibility study could lead to full multicentre trial Omega-3s fail to fix atrial fibrillation Renal denervation shows promise in refractory hypertension Catheter ablation of sympathetic nerves produces significant blood pressure reductions Report confirms disproportionate toll of drug abuse Giant rats detect TB Notorious autism paper a fraud, journal declares Hospital funding models need update: OMA New Ontario Medical Association paper considers activity-based funding versus global hospital funding New agent offers hope for rare bleeding disorder Recombinant factor XIII product reduced the number of bleeding episodes and avoided risks linked to blood products First Previous 364 365 366 367 368 Next Last
